Anteana Therapeutics Inc works in developing chronic pain and inflammation therapies involving inhibitors of N-acylethanolamine acid amide hydrolase (NAAA) molecules. The company grew out of research conducted by neuroscientist Daniele Piomelli at the University of California, Irvine, as well as the work of Dr. Miguel Garcia-Guzman, a specialist in pain pathologies and drug development.
